The importance of albuminuria in primary health care: prevention is better than cure

Authors

  • Ana Rita L. de Almeida Médica Interna de Nefrologia. Hospital Beatriz Ângelo, ULS Loures Odivelas. Loures, Portugal.
  • Ana Inês L. de Almeida Médica Especialista em Medicina Geral e Familiar. UCSP Castanheira de Pêra, ULS Coimbra. Castanheira de Pêra, Portugal.
  • Maria Fátima Castro Médica Interna de Medicina Geral e Familiar. USF Serra da Lousã, ULS Coimbra. Lousã, Portugal.

DOI:

https://doi.org/10.32385/rpmgf.v41i5.14075

Keywords:

Diabetes mellitus, Hypertension, Primary health care, Chronic kidney disease, Albuminuria

Abstract

This article discusses a study conducted in a Family Health Unit that assessed the follow-up of 126 patients with hypertension and/or diabetes mellitus, focusing on the determination of microalbuminuria, a significant marker of kidney disease and cardiovascular risk. The results showed that in most patients, albuminuria was measured annually using the albumin-to-creatinine ratio (ACR) in a random urine sample. Regarding nephroprotective and albuminuria-reducing therapies, angiotensin-converting enzyme inhibitors (ACEIs) were the preferred agents, while sodium-glucose cotransporter-2 inhibitors (SGLT2i) were used only in patients with higher ACR levels. Given the high prevalence of chronic kidney disease in Portugal, we consider it is extremely relevant to raise awareness about the importance of assessing albuminuria in primary health care to detect early signs of worsening renal function and initiate prognosis-modifying therapies.

Downloads

Download data is not yet available.

References

1. Sociedade Portuguesa de Nefrologia. Dados gerais do registo: tratamento de doença renal crónica terminal em Portugal, 2021. Lisboa: SPN; 2021.

2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314.

3. Marques da Silva P, Carvalho D, Nazaré J, Martins L, Aguiar C, Manso MC, et al. Prevalence of microalbuminuria in hypertensive patients with or without type 2 diabetes in a Portuguese primary care setting: the RACE (micRoAlbumin sCreening survEy) study. Rev Port Cardiol. 2015;34(4):237-46.

4. Ruilope LM, Ortiz A, Lucia A, Miranda B, Alvarez-Llamas G, Barderas MG, et al. Prevention of cardiorenal damage: importance of albuminuria. Eur Heart J. 2023;44(13):1112-23.

5. American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175-84. Erratum in: Diabetes Care. 2022;45(3):758. Diabetes Care. 2022;45(9):2182-4.

6. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1-S127.

7. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. Erratum in: Eur Heart J. 2019;40(5):475.

8. Tangri N, Ferguson TW, Wiebe C, Eng F, Nash M, Astor BC, et al. Validation of the kidney failure risk equation in kidney transplant recipients. Can J Kidney Health Dis. 2020;7:2054358120922627.

9. Silva BM, Charreu J, Duarte I, Outerelo C, Gameiro J. Validation of the kidney failure risk equation in a Portuguese cohort. Nefrologia (Engl Ed). 2023;43(4):467-73.

10. Santos-Araújo C, Mendonça L, Carvalho DS, Bernardo F, Pardal M, Couceiro J, et al. Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population. Clin Kidney J. 2022;16(1):111-24.

11. Vinhas J, Aires I, Batista C, Branco P, Brandão J, Nogueira R, et al. RENA study: cross-sectional study to evaluate CKD prevalence in Portugal. Nephron. 2020;144(10):479-87.

12. Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34-47.

13. Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD, et al. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129(2):153-162.e7.

14. Heerspink HJ, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-46.

Published

2025-11-03

How to Cite

The importance of albuminuria in primary health care: prevention is better than cure. (2025). Portuguese Journal of Family Medicine and General Practice, 41(5), 455-8. https://doi.org/10.32385/rpmgf.v41i5.14075